iShares Nasdaq US Biotechnology UCITS ETF Forecast

iShares Nasdaq US Biotechnology UCITS ETF price down 0.442% on Friday
(Updated on May 10, 2024)

BTEE.L Signals & Forecast

The iShares Nasdaq US Biotechnology UCITS ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at £6.28 and £6.19. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 07, 2024, and so far it has fallen -0.82%. Further fall is indicated until a new bottom pivot has been found. iShares Nasdaq US Biotechnology UCITS gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The ETF had a Golden Star Signal on Monday, June 12, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for iShares Nasdaq US Biotechnology UCITS ETF

iShares Nasdaq US Biotechnology UCITS finds support from accumulated volume at £6.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the ETF moved £0.0790 (1.25%) between high and low. For the last week, the ETF has had daily average volatility of 1.11%.

Our recommended stop-loss: £6.13 (-2.80%) (This ETF has low daily movements and this gives low risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (BTEE.L) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) to open at £6.33, and during the day (based on 14 day Average True Range), to move between £6.21 and £6.40, which gives a possible trading interval of +/-£0.0958 (+/-1.52%) up or down from last closing price. If iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) takes out the full calculated possible swing range there will be an estimated 3.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at £6.37 (0.94%) than the support at £6.21 (1.55%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) ETF A Buy?

iShares Nasdaq US Biotechnology UCITS holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) of Monday, May 13, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.